Catalog Number 07C18-29 |
Device Problem
High Test Results (2457)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Type
malfunction
|
Manufacturer Narrative
|
There is no further patient information provided by the customer.An evaluation is in process.A final report will be submitted when the evaluation is complete.This report is being filed on an international product, list number 7c18 that has a similar product distributed in the us, list number 1l82.
|
|
Event Description
|
The customer reported (b)(6) architect anti-hbs results on one patient.The results provided were: current = (b)(6) / 1 year ago (b)(6) / 2 years ago = (b)(6) / 3 years ago = (b)(6).The patient has not been vaccinated.There was no reported impact to patient management.
|
|
Manufacturer Narrative
|
A review of tickets or testing could not be completed as the lot is unknown.A complaint trending report review determined that there are no trends for the product for the complaint issue.Return testing was not completed as returns were not available.Historical performance in the field of architect anti-hbs reagent lots using world wide data through abbottlink was evaluated.All lots on market have median values that do not exceed 2sd above the established baselines, confirming no systemic issues in the field.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.A review of labeling concluded that the issue is sufficiently addressed in the labeling.Based on the investigation no product deficiency was identified for the architect anti-hbs assay.
|
|
Search Alerts/Recalls
|